Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,582.25
(
-0.64%
)
US TECH 100
23,609.20
(
-0.79%
)
Dow Jones
45,870.99
(
-0.77%
)
Brent Oil
104.34
(
-2.11%
)
Bitcoin
69,782.15
(
-2.05%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 127235

Friday, 09/23/2011 4:11:29 PM

Friday, September 23, 2011 4:11:29 PM

Post# of 257259

…BAX and SHPGY…

I could see SHPGY being interested in MNTA, but BAX is not a plausible fit, IMO. BAX strikes me as a ne’er-do-well company that probably makes more mistakes than any biotech company of its size. I have a heard time seeing BAX pull off a successful biogenerics program even with access to MNTA’s technology.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now